Publicité
Publicité
GTBP
GT Biopharma Inc. Common Stock
0.69
USDSponsorisé
+0.01
+0.74%
09 janv., 15:59 UTC -5
Fermé
Après-marché
0.68
-0.01
-0.88%
GTBP Rapports sur les bénéfices
Ratio de surprise positive
GTBP a dépassé 11 des 18 dernières estimations.
61%
Prochain rapport
Date du prochain rapport
19 févr. 2026
Estimate for Q4 25 (Revenue/ EPS)
--
/-$0.22
Variation implicite de Q3 25 (Revenue/ EPS)
--
/-72.15%
Variation implicite de Q4 24 (Revenue/ EPS)
--
/-86.75%
GT Biopharma Inc. Common Stock earnings per share and revenue
On 14 nov. 2025, GTBP reported earnings of -0.79 USD per share (EPS) for Q3 25, missing the estimate of -0.38 USD, resulting in a -103.82% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a -25.34% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 3 analystes forecast an EPS of -0.22 USD, with revenue projected to reach -- USD, implying an baisse of -72.15% EPS, and hausse of 0.00% in Revenue from the last quarter.
FAQ
What were GT Biopharma Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, GT Biopharma Inc. Common Stock reported EPS of -$0.79, missing estimates by -103.82%, and revenue of $0.00, 0% as expectations.
How did the market react to GT Biopharma Inc. Common Stock's Q3 2025 earnings?
The stock price moved down -25.34%, changed from $0.92 before the earnings release to $0.69 the day after.
When is GT Biopharma Inc. Common Stock expected to report next?
The next earning report is scheduled for 19 févr. 2026.
What are the forecasts for GT Biopharma Inc. Common Stock's next earnings report?
Based on 3
analystes, GT Biopharma Inc. Common Stock is expected to report EPS of -$0.22 and revenue of -- for Q4 2025.
Which companies are reporting earnings today?
Chèque FXEmpire's Earnings Calendar for today's list of reporting companies.
Publicité